SCM
LXRX icon

Sterling Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sterling Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Buy
+874
New +$1.7K ﹤0.01% 2982
2025
Q2 		– Sell
-1,280
Closed -$590 – 3336
2025
Q1 		$590 Sell
1,280
-1,197
-48% -$755 ﹤0.01% 2935
2024
Q4 		$1.83K Buy
2,477
+2,205
+811% +$2.66K ﹤0.01% 2806
2024
Q3 		$427 Buy
+272
New +$484 ﹤0.01% 2933
2017
Q1 		– Sell
-14,112
Closed -$195K – 981
2016
Q4 		$195K Hold
14,112
– – ﹤0.01% 911
2016
Q3 		$255K Buy
+14,112
New +$227K ﹤0.01% 830

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sterling Capital Management's LXRX Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 874 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #2982 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in LXRX as recently as Q1 2025.

Sterling Capital Management first reported a position in LXRX in Q3 2016 and has held it in 6 quarters since. The position peaked at $255K in Q3 2016. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Sterling Capital Management held 874 shares of Lexicon Pharmaceuticals worth $2.1K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Sterling Capital Management position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2982 holding.
  • Sterling Capital Management first reported a position in Lexicon Pharmaceuticals in Q3 2016 and has held it in 6 quarters since.
  • Sterling Capital Management's Lexicon Pharmaceuticals position peaked at $255K in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.